3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea,hydrochloride

We are 3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea,hydrochloride CAS:1083076-69-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms:
3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea,hydrochloride
Cariprazine hydrochloride
trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine monohydrochloride
Cariprazine hydrochloride [USAN]
Cariprazine hydrochloride (JAN/USAN)
Vraylar
UNII-KQD7C255YG
Cariprazine HCl
RGH-188 hydrochloride
RGH-188 HCL
3-(trans-4-{2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl}cyclohexyl)-1,1-dimethylurea hydrochloride (1:1)
Urea, N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethyl-, hydrochloride (1:1)
trans 4-{2-[4-(2,3-dichlorophenyl)-piperazine-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine hydrochloride
Cariprazine (hydrochloride)
 
Molecular Formula:  C21H33Cl3N4O
Molecular Weight:  463.87200

Items of Analysis Standard of Analysis Test Results
Appearance White solid Conforms
Identification HNMR
MS
Conforms
Conforms
Purity ≥98% 99.4%
The largest impurity ≤0.5% 0.3%
Conclusion Conforms to Factory Standard
 


3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea,hydrochloride


Related News: The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry.4-(2-bromo-5-isopropoxybenzyl)-1-(2-cyclopentylethyl)piperidine hydrochloride “Our priority is not only to protect and inform the residents of Boston but also to help this man continue to recover.Trimetilsilanol CAS:1066-40-6 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.4,4-diethyl-pyrazolidin-3-one This is how an API becomes a medicine.Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.

Related Products
Product Name
Hydriodic acid View Details
2-(2-chloroethoxy)-N-(oxomethylidene)benzenesulfonamide View Details
3-Ethynylimidazo[1,2-b]pyridazine View Details
2-chloro-5-(trifluoromethyl)benzenecarbonitrile manufacturer Pregnenolone acetate manufacturer 3-chloropropoxymethylbenzene manufacturer 1,3-difluoro-5-(trifluoromethyl)benzene manufacturer tert-butyl N-[(3S)-piperidin-3-yl]carbamate manufacturer